is semaglutide still on shortage list GLP-1 No Longer FDA's Drug FDA Warns on Certain Forms

Cold-chain delivery: insulated 28 C packaging, tracked and signed-for

Certain health conditions may disqualify someone from using GLP-1 medications

If you have an autoimmune disease, obesity, diabetes, high cholesterol, or heart concerns, do not wait until symptoms become serious

Holst JJ, rskov C, Nielsen OV, Schwartz TW

Continued dose escalation may occur through month 4 (moving from 0.5 mg to 1 mg for semaglutide injections), with maximum benefit typically reached around month 46

As a prebiotic, it selectively nourishes beneficial gut bacteria such as Bifidobacterium and Akkermansia muciniphila , which are associated with metabolic and intestinal health